Remdesivir reduced mortality in immunocompromised patients hospitalized for COVID-19 across variant waves: Findings from routine clinical practice

By sjmartinez • August 10, 2023

Mozaffari E, Chandak A, Gottlieb RL, Chima-Melton C, Read SH, Jiang H, Chiang M, Lee E, Gupta R, Berry M, Kalil AC. Remdesivir reduced mortality in immunocompromised patients hospitalized for COVID-19 across variant waves: Findings from routine clinical practice. Clin Infect Dis. 2023 Aug 9:ciad460. doi: 10.1093/cid/ciad460. Epub ahead of print. PMID: 37556727.

Tags: comparative effectiveness research, covid-19, immunocompromised, mortality, Publications, Pulmonary, Critical Care & Sleep Medicine, remdesivir, survival

The Long-term Value of Bariatric Surgery Interventions for American Adults With Type 2 Diabetes Mellitus

Chaturvedi R, Gracner T, Tysinger B, Narain K, Goldman D, Sturm R. The Long-term Value of Bariatric Surgery Interventions for American Adults With Type 2 ...

Surgeon-reported Factors Influencing Adoption of Quality Standards for Goal-concordant Care in Patients With Advanced Cancer: A Qualitative Study

Hu FY, Tabata-Kelly M, Johnston FM, Walling AM, Lindvall C, Bernacki RE, Pusic AL, Cooper Z. Surgeon-reported Factors Influencing Adoption of Quality Standards for Goal-concordant ...

Tapinarof cream 1% once daily for the treatment of adults with mild to severe plaque psoriasis: A novel topical therapy targeting the aryl hydrocarbon receptor

Armstrong AW, McConaha JL. Tapinarof cream 1% once daily for the treatment of adults with mild to severe plaque psoriasis: A novel topical therapy targeting ...